Evidence map›Paper›PMID 34346780›Full record

ArticleAmerican journal of physiology. Lung cellular and molecular physiology2021

Endothelial cell PHD2-HIF1α-PFKFB3 contributes to right ventricle vascular adaptation in pulmonary hypertension.

Biruk Kassa, Rahul Kumar, Claudia Mickael, Linda Sanders, Christine Vohwinkel, Michael H Lee, Sue Gu, Jens M Poth, Kurt R Stenmark, You-Yang Zhao and 2 more

Open access · greenAbstract read
In one paragraph

Article in American journal of physiology. Lung cellular and molecular physiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.2field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 21 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. PFKFB3 Inhibits Fructose Metabolism in Pulmonary Microvascular Endothelial Cells.American journal of respiratory cell and molecular biology · 2023
    Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 2 countries.

Biruk KassaDepartment of Medicine, University of California, San Francisco, San Francisco, California.
Rahul KumarDepartment of Medicine, University of California, San Francisco, San Francisco, California.
Claudia MickaelDepartment of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado.
Linda SandersDepartment of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado.
Christine VohwinkelKlinik und Poliklinik für Anästhesiologie und Operative Intensivmedizin, Universitätsklinikum Bonn, Bonn, Germany.
Michael H LeeDepartment of Medicine, University of California, San Francisco, San Francisco, California.
Sue GuDepartment of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado.
Jens M PothKlinik und Poliklinik für Anästhesiologie und Operative Intensivmedizin, Universitätsklinikum Bonn, Bonn, Germany.
Kurt R StenmarkDepartment of Pediatrics, University of Colorado Anschutz Medical Campus, Aurora, Colorado.
You-Yang ZhaoProgram for Lung and Vascular Biology, Stanley Manne Children's Research Institute, Ann & Robert Lurie Children's Hospital of Chicago, Chicago, Illinois.
Rubin M TuderDepartment of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado.
Brian B GrahamDepartment of Medicine, University of California, San Francisco, San Francisco, California.ORCID 0000-0001-7541-2585
University of Colorado Anschutz Medical Campus · USUniversity of California, San Francisco · USUniversity Hospital Bonn · DENorthwestern University · US

Funding

VRAC and Rho in pulmonary EC proliferationP01HL014985 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI STENMARK, KURT R. · 1985 to 2019
$35.1M
Role of Complement-Driven Pulmonary Vascular Inflammation in PHP01HL152961 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI STENMARK, KURT R. · 2020 to 2024
$14.1M
Investigating paclitaxel treatment in a pre-clinical model of Schistosoma-pulmonary hypertensionR01HL135872 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI Brian Barkley Graham · 2017 to 2026
$5.1M
Novel mechanisms of obliterative pulmonary vascular remodeling and sever pulmonary arterial hypertensionR01HL133951 · NHLBI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI ZHAO, YOU-YANG · 2016 to 2024
$4.9M
Novel mechanisms of endothelial Injury in the pathogenesis of ARDSR01HL148810 · NHLBI · LURIE CHILDREN'S HOSPITAL OF CHICAGO · PI ZHAO, YOU-YANG · 2020 to 2023
$2.3M
Targeting Smooth Muscle Progenitor Cells for Treatment of Pulmonary Arterial HypertensionR01HL140409 · NHLBI · LURIE CHILDREN'S HOSPITAL OF CHICAGO · PI ZHAO, YOU-YANG · 2018 to 2021
$2.0M
Alveolar epithelial carbohydrate metabolism in acute lung injuryK08HL130586 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI VOHWINKEL, CHRISTINE U · 2018 to 2022
$695k
Small Animal Ultrasound Imager - Vevo 2100S10OD018156 · OD · UNIVERSITY OF COLORADO DENVER · PI BUTTRICK, PETER N., MCKINSEY, TIMOTHY · 2014 to 2014
$506k
HHS | National Institutes of Health (NIH) P01HL014985NHLBI NIH HHS K08 HL130586NHLBI NIH HHS P01 HL014985NHLBI NIH HHS P01 HL152961NHLBI NIH HHS R01 HL133951NHLBI NIH HHS R01 HL135872NHLBI NIH HHS R01 HL140409NHLBI NIH HHS R01 HL148810NIH HHS S10 OD018156
6 · The paper itself

Abstract

Humans and animals with pulmonary hypertension (PH) show right ventricular (RV) capillary growth, which positively correlates with overall RV hypertrophy. However, molecular drivers of RV vascular augmentation in PH are unknown. Prolyl hydroxylase (PHD2) is a regulator of hypoxia-inducible factors (HIFs), which transcriptionally activates several proangiogenic genes, including the glycolytic enzyme 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 (PFKFB3). We hypothesized that a signaling axis of PHD2-HIF1α-PFKFB3 contributes to adaptive coupling between the RV vasculature and tissue volume to maintain appropriate vascular density in PH. We used design-based stereology to analyze endothelial cell (EC) proliferation and the absolute length of the vascular network in the RV free wall, relative to the tissue volume in mice challenged with hypoxic PH. We observed increased RV EC proliferation starting after 6 h of hypoxia challenge. Using parabiotic mice, we found no evidence for a contribution of circulating EC precursors to the RV vascular network. Mice with transgenic deletion or pharmacological inhibition of PHD2, HIF1α, or PFKFB3 all had evidence of impaired RV vascular adaptation following hypoxia PH challenge. PHD2-HIF1α-PFKFB3 contributes to structural coupling between the RV vascular length and tissue volume in hypoxic mice, consistent with homeostatic mechanisms that maintain appropriate vascular density. Activating this pathway could help augment the RV vasculature and preserve RV substrate delivery in PH, as an approach to promote RV function.

Indexed as

AnaerobiosisAnimalsCoronary VesselsEndothelial CellsFemaleHeart VentriclesHypertension, PulmonaryHypoxia-Inducible Factor 1, alpha SubunitHypoxia-Inducible Factor-Proline DioxygenasesMiceMice, Inbred C57BLMice, KnockoutNeovascularization, PhysiologicPhosphofructokinase-2Signal TransductionEgln1 protein, mouseHif1a protein, mouseHypoxia-Inducible Factor 1, alpha SubunitHypoxia-Inducible Factor-Proline DioxygenasesPFKFB3 protein, mousePhosphofructokinase-2pulmonary hypertensionright ventriclestereologyvascular adaptation

Identifiers

PMID34346780
PMCPMC8560395
OpenAlexW3193103357

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.